Ontology highlight
ABSTRACT: Objective
Acute myeloid leukemia (AML) patients with internal tandem duplications in the FMS-like tyrosine kinase 3 receptor gene (FLT3-ITD) receiving tyrosine kinase inhibitors maintenance after allogeneic hematopoietic stem cell transplantation (allo-HSCT) demonstrated improved survival outcomes, however, some still experienced relapse during the maintenance. This study aimed to explore risk factors which might be indicators for poor survival after allo-HSCT in this population.Methods
We consecutively enrolled FLT3-ITD AML patients undergoing transplantation at three centers. By integrating genetic profiles with clinical information, we assessed their impact on transplant outcomes.Results
A total of 196 patient were eligible in the analysis, among wh
SUBMITTER: Zhao Y
PROVIDER: S-EPMC12444344 | biostudies-literature | 2025 Aug
REPOSITORIES: biostudies-literature